Hasan Akbaba

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Klebsiella Pneumoniae

Magnetic Nanoparticles

Top Venues

Nanomedicine (London, England)

Archiv der Pharmazie

Pharmaceutical research

Marmara Üniversitesi Eczacılık Fakültesi (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Marmara Üniversitesi Eczacılık Fakültesi Feb 15 2010 - Feb 15 2016

Turkey

PHD :: Pharmaceutical Biotechlogy

Ege Üniversitesi Eczacılık Fakültesi Sep 15 2003 - Sep 15 2007

Turkey

PHD :: Pharmaceutical Biotechnology

Publications

Hasan Akbaba, Gülşah Erel-Akbaba, Yücel Başpınar, Şerif Şentürk
Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders. ACS omega 8 (48) (2023)
Hasan Akbaba, Gulsah Erel-Akbaba, Serif Senturk
Special Focus Issue Part II: Recruitment of solid lipid nanoparticles for the delivery of CRISPR/Cas9: primary evaluation of anticancer gene editing. Nanomedicine (London, England) 16 (12) (2021)
Huseyin Istanbullu, Gülşah Bayraktar, Hasan Akbaba, Ibrahim Cavus, Güneş Çoban, Bilge Debelec Butuner, Ali Ahmet Kilimcioglu, Ahmet Özbilgin, Vildan Alptuzun, Ercin Erciyas
Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds. Archiv der Pharmazie 353 (8) (2020)
Hasan Akbaba, Gülşah Erel-Akbaba, Mustafa Kotmakçı, Yücel Başpınar
Enhanced Cellular Uptake and Gene Silencing Activity of Survivin-siRNA via Ultrasound-Mediated Nanobubbles in Lung Cancer Cells. Pharmaceutical research 37 (8) (2020)